Péptidos

Updated July 24, 2026: This article reflects the PCAC votes completed on July 23 & 24. The FDA’s Pharmacy Compounding Advisory Committee, commonly called PCAC, has completed the first round of voting in its closely watched review of several peptide-related bulk drug substances. On July 23 & 24 , 2026, committee members voted in favor

Last updated July 16, 2026. This article reflects FDA information available as of this date. Earlier this summer , we shared our first peptide update after the FDA announced that its Pharmacy Compounding Advisory Committee, known as PCAC, would meet on July 23 and 24, 2026. The main point of that article still stands: an

Interest in peptides has grown rapidly in anti-aging and hormone optimization circles. Walk into any longevity clinic today and you’ll hear names like sermorelin peptide, BPC-157, ipamorelin, and CJC-1295 tossed around as if they are interchangeable. They are not. These compounds differ in how they work, what they target, how long they stay active in